On Monday, the pharmaceutical company Pfizer Pfizer said the 20vPnC vaccine is for the “prevention of invasive disease and pneumonia caused by 20 serotypes of Streptococcus pneumonia in the vaccine in adult’s ages 18 years and older.”
Pfizer Researching On A Booster Shot To Work With All Vaccines
The company will be enrolling 600 samples 65 and older to receive the immunizations. The objective of the study is to test if both vaccines are safe when they are co-administered. This will have a follow-up six months after vaccination. To describe immune responses produced by each of the vaccines.
The individuals who will be tested for the vaccine will be from the third phase of the Pfizer-Biotech COVID-19 vaccine trial. They will have received their second dose of the vaccine at least six months before entering the new study.
- All subjects will vibe placed into any of the three groups, one with the 20vPnC plus Pfizer-BioNTech COVID-19 vaccine booster, which is a third dose of the Pfizer-BioNTech COVID-19 Vaccine,
- Another group will receive a placebo
- -BioNTech COVID-19 vaccine booster plus a placebo.
The booster will be the third dose that Americans will need to take yearly to prevent new strains. Researchers are also testing how it will work with other common vaccines Dr. Sunil Joshi, the president of the Duval County Medical Society Foundation, also said they have been wondering about the booster and if it could work with other vaccines. There is going to be a booster every fall, and therefore, there was a need to know whether it could work with other vaccines a third dose the company’s CEO said fully vaccinated people will likely need in another 12 months.
During the study, the participants will get the booster shot and the pneumonia vaccine. The goal of the study is to see whether another vaccine can be taken along with a booster dose of Pfizer’s COVID-19 vaccine.
In December 2020, the U.S. Food and Drug Administration accepted a priority review of Pfizer’s biologics license application for the investigational 20vPnC in adults over 18 and set an action date for a decision in June. The European Medicines Agency (EMA) in February of this year accepted for review the marketing authorization application for 20vPnC for adult’s ages 18 years and older. The FDA has already authorized the use of the Pfizer-BioNTech COVID-19 vaccine back in December under the Emergency Use Authorization. To help the nation in combating the coronavirus pandemic.
At the same time, the Center for Disease Control and Prevention is investigating several reports that teenagers and young adults may have developed a heart problem known as myocarditis days after getting vaccinated. However, the agency has not determined if there’s evidence that the shots actually caused the heart condition.
“The concerns are very preliminary, and I advise not to get overly concerned about it until the details are finned out,” said Dr. Michael Koran, a cardiologist and the director of research at the Jacksonville Center for Clinical Research. There are high chances that these will be random cases.
However, Dr. Anthony Fauci says vaccinated Americans may not need to get booster shots this fall for further protection from COVID-19. Fauci, the US leading infectious disease expert, told CBS “on Friday. He also said that scientists would be tracking current data on the virus and possible variants. He said the experts will advise on which direction to take even if they felt a third shot was necessary. Dr. Fauci added that those who have not been vaccinated should continue wearing their mask even when they are with vaccinated people. He urged everyone to follow CDC guidelines.